CalciMedica, Inc.
Cash Flow Statement
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-7.7M | $5.0M | $-10.8M | $-7.8M | $-6.0M | $-5.0M | $-4.3M | $-5.6M |
| Depreciation & Amortization | — | — | — | — | — | — | — | — |
| Depreciation | $7.0K | $7.0K | $5.0K | $12.0K | $14.0K | $15.0K | $13.0K | $15.0K |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | $540.0K | $561.0K | $622.0K | $625.0K | $1.2M | $549.0K | $632.0K | $781.0K |
| Net Cash from Operating Activities | $-4.6M | $-4.9M | $-4.9M | $-4.8M | $-6.7M | $-4.9M | $-5.0M | $-4.7M |
| Investing Activities | ||||||||
| Capital Expenditures | $0 | $0 | $6.0K | $8.0K | $5.0K | $9.0K | $2.0K | $6.0K |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $42.0K | $1.5M | $7.1M | $3.5M | $134.0K | $-1.2M | $-5.2M | $8.7M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $15.0M | $0 | $3.8M | $818.0K | $-102.0K | $10.7M | $8.9M | $16.0K |
| Net Change in Cash | $10.5M | $-3.4M | $6.1M | $-448.0K | $-6.6M | $4.6M | $-1.2M | $4.1M |
| Free Cash Flow | $-4.6M | $-4.9M | $-4.9M | $-4.8M | $-6.7M | $-4.9M | $-5.0M | $-4.7M |